MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 19.03.2026
Assembly Biosciences P/B 2011-2026 | ASMB
P/B Jährlich Assembly Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.49 | 4.95 | 1.48 | 0.062 | 0.397 | 0.824 | 1.7 | 2.38 | 7.85 | 4.09 | 0.677 | 1 | 3.1 | 1.81 | 2.44 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.85 | 0.062 | 2.28 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Grifols, S.A.
GRFS
|
1.15 | $ 7.68 | - | $ 6.83 B |  Spain |
 |
Altimmune
ALT
|
1.41 | $ 3.47 | 3.74 % | $ 306 M |  USA |
 |
Amgen
AMGN
|
2.19 | - | - | $ 188 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 | - | - | $ 915 M | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Heron Therapeutics
HRTX
|
13.8 | - | - | $ 130 M | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 218.0 | -1.75 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Incyte Corporation
INCY
|
3.77 | $ 90.75 | -0.03 % | $ 17.7 B | USA |
 |
Inovio Pharmaceuticals
INO
|
1.88 | $ 1.57 | -0.63 % | $ 34.8 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Cullinan Management
CGEM
|
2.2 | $ 12.91 | 1.33 % | $ 778 M | USA |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Inventiva S.A.
IVA
|
6.02 | $ 6.11 | 5.71 % | $ 138 M | France |
 |
Calithera Biosciences
CALA
|
19.6 | - | -10.95 % | $ 876 K | USA |
 |
Cara Therapeutics
CARA
|
0.949 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
0.00635 | - | - | $ 3.74 B | USA |
 |
Bellerophon Therapeutics
BLPH
|
31 | - | -74.18 % | $ 955 K | USA |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
3.07 | $ 16.73 | -1.59 % | $ 831 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Denali Therapeutics
DNLI
|
2.47 | $ 21.04 | 4.31 % | $ 3.46 B | USA |
 |
Kamada Ltd.
KMDA
|
0.85 | $ 8.27 | 0.24 % | $ 260 M | Israel |
 |
Karyopharm Therapeutics
KPTI
|
-0.000393 | $ 6.93 | -9.17 % | $ 845 K | USA |
 |
Keros Therapeutics
KROS
|
1.69 | $ 11.17 | 1.92 % | $ 416 M | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.3 | 1.37 % | $ 714 M | Canada |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |